I saw the presentation (not paying full attention) and didn't get a high confidence in the presentation to bother to pursue DD. The slides had the lower dose (combined with Aricept I believe) matching the comparator alone at 24 or 48 weeks (don't recall). They did mention Lundbeck is in phase 3 with 5-HT6 antagonist.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.